针对糖尿病心肌病中的自:从分子机制到药理疗法
Jie Li1, Yingying Xie2, Shuwen Zheng3
1China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Beijing, China.
概括
糖尿病心肌病 (DCM) 涉及由于代谢问题的心脏功能障碍. 调节细胞自,一个细胞过程,通过向关键信号通路和使用天然产品或药物来治疗DCM显示出希望.
科学领域:
- 心脏病学 心脏病学
- 细胞生物学 细胞生物学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 糖尿病心肌病 (DCM) 是代谢障碍的心脏并发症,以心肌重塑和功能障碍为标志.
- 异常的细胞代谢和有机细胞积累是DCM病变发生的核心.
- 自在糖尿病心脏中起着至关重要的作用,建议它作为治疗点.
研究的目的:
- 审查在DCM中调节自的信号通路.
- 为了确定自然产品和化学药物,调节自为DCM治疗.
- 提高对DCM药物治疗和临床应用中的自机制的理解.
主要方法:
- 在DCM相关的自中信号通路的文献综述.
- 确定在DCM中向自的自然产品和化学药物.
- 对DCM对自调节的当前研究进行综合.
主要成果:
- 在DCM中确定了调节自的关键信号通路:AMPK,mTOR,FOXOs,SIRTuins和PINK1/Parkin.
- 自然产品和化学药物作为DCM的自调节剂被目录.
- 证据支持自调节作为DCM的可行的治疗策略.
结论:
- 自是糖尿病心肌病的关键机制.
- 用特定药物或天然产品准自途径为DCM提供了潜在的治疗益处.
- 对自调节的进一步研究可以促进糖尿病心脏病的临床治疗.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
265
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
265
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K